Patents by Inventor Oksana Yakovleva

Oksana Yakovleva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9051390
    Abstract: A pharmaceutical formulation and method of treatment of prion disease include a RAP agent with a pharmaceutically acceptable carrier and/or excipient, and the administration of same to a subject suffering from or at risk of a prion disease. The RAP agent is an effective means for the prevention and/or treatment of various prion diseases regardless whether the disease is acquired by infection or by genetic mutation.
    Type: Grant
    Filed: May 17, 2010
    Date of Patent: June 9, 2015
    Assignee: American National Red Cross
    Inventors: Larisa Cervenakova, Oksana Yakovleva
  • Publication number: 20120135936
    Abstract: A pharmaceutical formulation and method of treatment of prion disease include a RAP agent with a pharmaceutically acceptable carrier and/or excipient, and the administration of same to a subject suffering from or at risk of a prion disease. The RAP agent is an effective means for the prevention and/or treatment of various prion diseases regardless whether the disease is acquired by infection or by genetic mutation.
    Type: Application
    Filed: May 17, 2010
    Publication date: May 31, 2012
    Applicant: AMERICAN NATIONAL RED CROSS
    Inventors: Larisa Cervenakova, Oksana Yakovleva
  • Publication number: 20050032138
    Abstract: A method of identifying a ligand specific for a structural isoform of a protein by the binding of the structural isoform to a ligand on a support, a direct positional transfer of the structural isoform and a control isoform between two or more different solid or semi-solid supports and detection of at least one of the isoforms on each support, thus allowing for subtractive identification techniques to be used to identify the subset of ligands, or a ligand, specific for the structural isoform.
    Type: Application
    Filed: April 14, 2004
    Publication date: February 10, 2005
    Inventors: Julia Lathrop, David Hammond, Larisa Cervenakova, Liliana Gheorghiu, Oksana Yakovleva